Vepesid

What it is used for

1 – small cell carcinoma of the lung 2 – acutre monocytic and myelomoncytic leukaemia 3 – Hodgkins disease 4 -Non-Hodgkins lymphomaa INDICATIONS AS AT 5 OCTOBER 2000: In the treatment of: 1. Small cell carcinoma of the lung. 2. Acute monocytic and myelomonocytic leukaemia. 3. Hodgkin’s disease. 4. Non-Hodgkin’slymphomaa.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 3 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 3 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Pregnant or planning a pregnancy?

For the active ingredient etoposide

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.

Visual appearance

Opaque, pink, oval, soft gelatin capsules diameter 10mm, length 24mm

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.